234 related articles for article (PubMed ID: 10895368)
1. Birmingham vasculitis activity score, disease extent index and complement factor C3c reflect disease activity best in hepatitis C virus-associated cryoglobulinemic vasculitis.
Lamprecht P; Moosig F; Gause A; Herlyn K; Gross WL
Clin Exp Rheumatol; 2000; 18(3):319-25. PubMed ID: 10895368
[TBL] [Abstract][Full Text] [Related]
2. Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis.
Lamprecht P; Moosig F; Gause A; Herlyn K; Csernok E; Hansen H; Gross WL
Ann Rheum Dis; 2001 Apr; 60(4):385-90. PubMed ID: 11247870
[TBL] [Abstract][Full Text] [Related]
3. [Hepatitis C virus-associated cryoglobulinemic vasculitis: A 20-year experience with treatment].
Ignatova TM; Kozlovskaya LV; Gordovskaya NB; Chernova OA; Milovanova SY; Novikov PI; Nekrasova TP; Beketova TV; Mukhin NA
Ter Arkh; 2017; 89(5):46-52. PubMed ID: 28631698
[TBL] [Abstract][Full Text] [Related]
4. PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
Cacoub P; Saadoun D; Limal N; Sene D; Lidove O; Piette JC
Arthritis Rheum; 2005 Mar; 52(3):911-5. PubMed ID: 15751068
[TBL] [Abstract][Full Text] [Related]
5. Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.
Comarmond C; Garrido M; Pol S; Desbois AC; Costopoulos M; Le Garff-Tavernier M; Si Ahmed SN; Alric L; Fontaine H; Bellier B; Maciejewski A; Rosenzwajg M; Klatzmann D; Musset L; Poynard T; Cacoub P; Saadoun D
Gastroenterology; 2017 Jun; 152(8):2052-2062.e2. PubMed ID: 28274850
[TBL] [Abstract][Full Text] [Related]
6. Causes and predictive factors of mortality in a cohort of patients with hepatitis C virus-related cryoglobulinemic vasculitis treated with antiviral therapy.
Landau DA; Scerra S; Sene D; Resche-Rigon M; Saadoun D; Cacoub P
J Rheumatol; 2010 Mar; 37(3):615-21. PubMed ID: 20110523
[TBL] [Abstract][Full Text] [Related]
7. Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis.
Landau DA; Rosenzwajg M; Saadoun D; Trébeden-Negre H; Klatzmann D; Cacoub P
Arthritis Rheum; 2008 Sep; 58(9):2897-907. PubMed ID: 18759287
[TBL] [Abstract][Full Text] [Related]
8. Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study.
Saadoun D; Resche-Rigon M; Thibault V; Piette JC; Cacoub P
Arthritis Rheum; 2006 Nov; 54(11):3696-706. PubMed ID: 17075881
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in severe cryoglobulinaemic vasculitis and improvement after B-cell depleting therapy.
Quartuccio L; Isola M; Masolini P; Scaini P; Zani R; Tavoni A; Pietrogrande M; Bombardieri S; De Vita S
Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S9-14. PubMed ID: 23044040
[TBL] [Abstract][Full Text] [Related]
10. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure.
Bonacci M; Lens S; Mariño Z; Londoño MC; Rodriguez-Tajes S; Sánchez-Tapias JM; Ramos-Casals M; Hernández-Rodríguez J; Forns X
Gastroenterology; 2018 Aug; 155(2):311-315.e6. PubMed ID: 29705529
[TBL] [Abstract][Full Text] [Related]
12. [Hepatitis C virus-related cryoglobulinemic vasculitis with renal involvement: current possibilities of treatment].
Gordovskaia NB; Kozlovskaia LV; Milovanova SIu; Ignatova TM; Korotchaeva IuV
Ter Arkh; 2013; 85(6):78-84. PubMed ID: 23866603
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.
Hu W; Liu C; Xie H; Chen H; Liu Z; Li L
Nephrol Dial Transplant; 2008 Apr; 23(4):1307-12. PubMed ID: 18065810
[TBL] [Abstract][Full Text] [Related]
14. Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study.
Mazzaro C; Zorat F; Caizzi M; Donada C; Di Gennaro G; Maso LD; Carniello G; Virgolini L; Tirelli U; Pozzato G
J Hepatol; 2005 May; 42(5):632-8. PubMed ID: 15826710
[TBL] [Abstract][Full Text] [Related]
15. Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature.
Giuggioli D; Manfredi A; Colaci M; Manzini CU; Antonelli A; Ferri C
Autoimmun Rev; 2013 Sep; 12(11):1058-63. PubMed ID: 23806565
[TBL] [Abstract][Full Text] [Related]
16. Treatment of mixed cryoglobulinemia: a rheumatology perspective.
De Vita S
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S99-103. PubMed ID: 21586203
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection.
Antonelli A; Ferri C; Ferrari SM; Ghiri E; Marchi S; Sebastiani M; Fallahi P
J Rheumatol; 2010 Jan; 37(1):91-7. PubMed ID: 19918044
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.
De Vita S; Quartuccio L; Isola M; Mazzaro C; Scaini P; Lenzi M; Campanini M; Naclerio C; Tavoni A; Pietrogrande M; Ferri C; Mascia MT; Masolini P; Zabotti A; Maset M; Roccatello D; Zignego AL; Pioltelli P; Gabrielli A; Filippini D; Perrella O; Migliaresi S; Galli M; Bombardieri S; Monti G
Arthritis Rheum; 2012 Mar; 64(3):843-53. PubMed ID: 22147661
[TBL] [Abstract][Full Text] [Related]
19. [Current possibilities for treatment for hepatitis C virus-induced cryoglobulinemic vasculitis and B-cell lymphoma].
Ignatova TM; Mukhin NA
Ter Arkh; 2012; 84(11):81-8. PubMed ID: 23252255
[TBL] [Abstract][Full Text] [Related]
20. PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis.
Saadoun D; Resche Rigon M; Pol S; Thibault V; Blanc F; Pialoux G; Karras A; Bazin-Kara D; Cazorla C; Vittecoq D; Musset L; Peltier J; Decaux O; Ziza JM; Lambotte O; Cacoub P
J Hepatol; 2015 Jan; 62(1):24-30. PubMed ID: 25135864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
